Aligos Therapeutics shares are trading lower after the company announced $92 million in private placement financing.
Portfolio Pulse from Benzinga Newsdesk
Aligos Therapeutics has announced $92 million in private placement financing, causing its shares to trade lower.
October 23, 2023 | 3:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aligos Therapeutics' shares are trading lower following the announcement of $92 million in private placement financing.
The announcement of private placement financing often leads to a dilution of shares, which can result in a decrease in the stock price. This is likely the reason for the drop in Aligos Therapeutics' share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100